These findings underscore the important role of IL-13 and its downstream signaling pathways, particularly through EGR-1 and TGF-β1, in the pathogenesis of intestinal fibrosis, highlighting potential therapeutic targets for fibrosis modulation in colitis. This evidence concerns the gene IL13 and colitis.